Screening of differentially expressed genes in male idiopathic osteoporosis via RNA sequencing

Feng,Li; Wang,Yan; Zhou,Jing; Tian,Baofang; Xia,Bo

doi:10.3892/mmr.2018.8985

Screening of differentially expressed genes in male idiopathic osteoporosis via RNA sequencing

Authors:
- Li Feng
- Yan Wang
- Jing Zhou
- Baofang Tian
- Bo Xia
View Affiliations

Affiliations: Department of Orthopedics, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China, Department of Gynecology, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China
Published online on: May 7, 2018 https://doi.org/10.3892/mmr.2018.8985
Pages: 67-76
Copyright: © Feng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

As a type of osteoporosis (OP), male idiopathic OP (MIO) is a bone disorder that occurs in young males and is a public health problem worldwide. However, the detailed pathogenesis of MIO remains to be elucidated. In the present study, blood samples of patients with MIO, senile OP, postmenopausal OP and normal controls (NCs) were obtained for RNA sequencing. Compared with the NC group, differentially expressed genes (DEGs) in the three types of OP were identified. DEGs that were common among the three types of OP and the DEGs that were unique to patients with MIO were determined. Gene ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were conducted. MIO‑specific and OP‑specific protein‑protein interaction (PPI) networks were constructed. Compared with NCs, a total of 519, 368 and 1,472 DEGs were identified in samples from MIO, senile OP and postmenopausal OP, respectively. Tetraspanin 5 (TSPAN5) and α‑synuclein (SNCA) were unique DEGs in MIO that were not identified in the other two types of OP compared with NCs. Furthermore, the expression of carbonic anhydrase 1 (CA1) and S100 calcium‑binding protein P (S100P) in MIO was significantly different compared with senile OP, postmenopausal OP and NC samples. ‘MAPK signaling pathway’, ‘type I diabetes mellitus’ and ‘hematopoietic cell lineage’ were among significantly enriched pathways of DEGs in MIO. SNCA and CDC‑like kinase 1 were the hub genes in the MIO‑specific PPI network. In conclusion, the mitogen‑activated protein kinase signaling and type I diabetes mellitus pathways may be involved in bone formation; SNCA and TSPAN5 may be associated with bone resorption. These two pathways and two genes may serve a role in MIO. CA1 and S100P may regulate the process of MIO by modulation of calcification and dysregulation of calcium binding. These findings may have provided an experimental basis for elucidating the underlying mechanisms and developing potential diagnostic biomarkers of MIO.

View Figures

View References

1	Karasik D, Rivadeneira F and Johnson ML: The genetics of bone mass and susceptibility to bone diseases. Nat Rev Rheumatol. 12:4962016. View Article : Google Scholar : PubMed/NCBI
2	Arjmandi BH, Johnson SA, Pourafshar S, Navaei N, George KS, Hooshmand S, Chai SC and Akhavan NS: Bone-protective effects of dried plum in postmenopausal women: Efficacy and possible mechanisms. Nutrients. 9:pii: E496. 2017. View Article : Google Scholar : PubMed/NCBI
3	Usman J and Siddiqui H: Osteoporosis in family practice. J Pak Med Assoc. 53:433–436. 2003.PubMed/NCBI
4	Brumsen C, Papapoulos SE, Lentjes EG, Kluin PM and Hamdy NA: A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men. Bone. 31:556–561. 2002. View Article : Google Scholar : PubMed/NCBI
5	Dudakovic A, Camilleri ET, Riester SM, Paradise CR, Gluscevic M, O'Toole TM, Thaler R, Evans JM, Yan H, Subramaniam M, et al: Enhancer of Zeste homolog 2 inhibition stimulates bone formation and mitigates bone loss caused by ovariectomy in skeletally mature mice. J Biol Chem. 291:24594–24606. 2016. View Article : Google Scholar : PubMed/NCBI
6	Lee YH, Kim JE, Roh YH, Choi HR, Rhee Y, Kang DR and Lim SK: The combination of vitamin D deficiency and mild to moderate chronic kidney disease is associated with low bone mineral density and deteriorated femoral microarchitecture: Results from the KNHANES 2008–2011. J Clin Endocrinol Metab. 99:3879–3888. 2014. View Article : Google Scholar : PubMed/NCBI
7	Klein-Nulend J, van Oers RF, Bakker AD and Bacabac RG: Bone cell mechanosensitivity, estrogen deficiency, and osteoporosis. J Biomech. 48:855–865. 2015. View Article : Google Scholar : PubMed/NCBI
8	Gielen E, Vanderschueren D, Callewaert F and Boonen S: Osteoporosis in men. Best Pract Res Clin Endocrinol Metab. 25:321–335. 2011. View Article : Google Scholar : PubMed/NCBI
9	Patsch JM, Kohler T, Berzlanovich A, Muschitz C, Bieglmayr C, Roschger P, Resch H and Pietschmann P: Trabecular bone microstructure and local gene expression in iliac crest biopsies of men with idiopathic osteoporosis. J Bone Miner Res. 26:1584–1592. 2011. View Article : Google Scholar : PubMed/NCBI
10	Paccou J, Dewailly J and Cortet B: Reduced levels of serum IGF-1 is related to the presence of osteoporotic fractures in male idiopathic osteoporosis. Joint Bone Spine. 79:78–82. 2012. View Article : Google Scholar : PubMed/NCBI
11	Muschitz C, Kocijan R, Pahr D, Patsch JM, Amrein K, Misof BM, Kaider A, Resch H and Pietschmann P: Ibandronate increases sclerostin levels and bone strength in male patients with idiopathic osteoporosis. Calcif Tissue Int. 96:477–489. 2015. View Article : Google Scholar : PubMed/NCBI
12	Mohammadi Z, Keshtkar A, Fayyazbakhsh F, Ebrahimi M, Amoli MM, Ghorbani M, Khashayar P, Dini M, Ebrahimi-Rad M and Larijani B: Prevalence of osteoporosis and vitamin D receptor gene polymorphisms (FokI) in an Iranian general population based study (Kurdistan) (IMOS). Med J Islam Repub Iran. 29:2382016.
13	Andrews S: FastQC A Quality Control tool for High Throughput Sequence Data. 2014.
14	Martin M: Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17:2011. View Article : Google Scholar
15	Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL and Pachter L: Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 7:562–578. 2012. View Article : Google Scholar : PubMed/NCBI
16	Ai H, Ai Y and Meng F: GenomeLandscaper: Landscape analysis of genome-fingerprints maps assessing chromosome architecture. Sci Rep. 8:10262018. View Article : Google Scholar : PubMed/NCBI
17	Gheinani Hashemi A, Burkhard FC, Rehrauer H, Fournier Aquino C and Monastyrskaya K: MicroRNA MiR-199a-5p regulates smooth muscle cell proliferation and morphology by targeting WNT2 signaling pathway. J Biol Chem. 290:7067–7086. 2015. View Article : Google Scholar : PubMed/NCBI
18	Tabas-Madrid D, Nogales-Cadenas R and Pascual-Montano A: GeneCodis3: A non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res. 40:(Web Server Issue). W478–W483. 2012. View Article : Google Scholar : PubMed/NCBI
19	Demchak B, Hull T, Reich M, Liefeld T, Smoot M, Ideker T and Mesirov JP: Cytoscape: The network visualization tool for GenomeSpace workflows. F1000Res. 3:1512014.PubMed/NCBI
20	Kim EK and Choi EJ: Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 1802:396–405. 2010. View Article : Google Scholar : PubMed/NCBI
21	Che J P, Li W, Yan Y, Liu M, Wang GC, Li QY, Yang B, Yao XD and Zheng JH: Expression and clinical significance of the nin one binding protein and p38 MAPK in prostate carcinoma. Int J Clin Exp Pathol. 6:2300–2311. 2013.PubMed/NCBI
22	Kim HK, Kim MG and Leem KH: Osteogenic activity of collagen peptide via ERK/MAPK pathway mediated boosting of collagen synthesis and its therapeutic efficacy in osteoporotic bone by back-scattered electron imaging and microarchitecture analysis. Molecules. 18:15474–15489. 2013. View Article : Google Scholar : PubMed/NCBI
23	Hah YS, Kang HG, Cho HY, Shin SH, Kim UK, Park BW, Lee SI, Rho GJ, Kim JR and Byun JH: JNK signaling plays an important role in the effects of TNF-α and IL-1β on in vitro osteoblastic differentiation of cultured human periosteal-derived cells. Mol Biol Rep. 40:4869–4881. 2013. View Article : Google Scholar : PubMed/NCBI
24	Zhou J, Fujiwara T, Ye S, Li X and Zhao H: Downregulation of Notch modulators, tetraspanin 5 and 10, inhibits osteoclastogenesis in vitro. Calcif Tissue Int. 95:209–217. 2014. View Article : Google Scholar : PubMed/NCBI
25	Kim DY, Kim GW and Chung SH: Nectandrin a enhances the BMP-induced osteoblastic differentiation and mineralization by activation of p38 MAPK-Smad signaling pathway. Korean J Physiol Pharmacol. 17:447–453. 2013. View Article : Google Scholar : PubMed/NCBI
26	Li J, Zhang L, Zhou L, Yu ZP, Qi F, Liu B, Zi SX, Li L, Li Y, Wang SB, et al: Beneficial effects of non-matched allogeneic cord blood mononuclear cells upon patients with idiopathic osteoporosis. J Transl Med. 10:1022012. View Article : Google Scholar : PubMed/NCBI
27	Yong L, Chengjun H, Jinhua SH and Paul J: possible linkage between osteoporosis and genes associated with type 1 diabetes mellitus. Med One. 1:e1700012017.
28	Calabrese G, Mesner LD, Foley PL, Rosen CJ and Farber CR: Network analysis implicates alpha-synuclein (Snca) in the regulation of ovariectomy-induced bone loss. Sci Rep. 6:294752016. View Article : Google Scholar : PubMed/NCBI
29	Bohaty I, Jurásné-Lukovics M, Somogyiné-Vári É, Kozma L, Dankó K and Molnár I: HLA class I, Cw01 and Cw15 alleles can play a preventing role in serum IL17 elevation associated with postmenopausal osteoporosis in Hungary. Endocrine. Apr 27–2013.DOI: 10.1530/endoabs.32.P85.
30	Alam I, Carr LG, Liang T, Liu Y, Edenberg HJ, Econs MJ and Turner CH: Identification of genes influencing skeletal phenotypes in congenic P/NP rats. J Bone Mineral Res. 25:1314–1325. 2010. View Article : Google Scholar
31	Jain P, Karthikeyan C, Moorthy NS, Waiker DK, Jain AK and Trivedi P: Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease. Curr Drug Targets. 15:539–550. 2014. View Article : Google Scholar : PubMed/NCBI
32	Chang X, Zheng Y, Yang Q, Wang L, Pan J, Xia Y, Yan X and Han J: Carbonic anhydrase I (CA1) is involved in the process of bone formation and is susceptible to ankylosing spondylitis. Arthrit Res Ther. 14:R1762012. View Article : Google Scholar
33	Li W, Chen WS, Zhou PP, Cao L and Yu LJ: Influence of initial pH on the precipitation and crystal morphology of calcium carbonate induced by microbial carbonic anhydrase. Colloids Surf B Biointerfaces. 102:281–287. 2013. View Article : Google Scholar : PubMed/NCBI
34	Chang X, Han J, Zhao Y, Yan X, Sun S and Cui Y: Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis. BMC Musculoskelet Disord. 11:2792010. View Article : Google Scholar : PubMed/NCBI
35	Tóthová V and Gibadulinová A: S100P, a peculiar member of S100 family of calcium-binding proteins implicated in cancer. Acta Virol. 57:238–246. 2013. View Article : Google Scholar : PubMed/NCBI
36	Li XL, Wu MS, Zhu XW, Deng YC, Ye YY, Zhao SZ, Ren LZ and Li B: Effects of flavonoids from Cuscuta chinensis on intestinal calcium-binding protein mRNA expression in ovariectomized osteoporosis model rats. Chin J Tissue Eng Res. 4271–4276. 2014.